Suresh S Ramalingam Selected Research

BXI-61

9/2013

Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suresh S Ramalingam Research Topics

Disease

148	Neoplasms (Cancer) 03/2024 - 06/2007
147	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 06/2007
69	Lung Neoplasms (Lung Cancer) 05/2024 - 11/2010
26	Disease Progression 11/2023 - 11/2008
20	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2023 - 03/2010
13	Neoplasm Metastasis (Metastasis) 03/2023 - 01/2016
8	Fatigue 02/2024 - 06/2008
8	Adenocarcinoma of Lung 09/2020 - 12/2015
6	Diarrhea 02/2024 - 08/2010
6	Brain Neoplasms (Brain Tumor) 01/2023 - 02/2012
6	Neutropenia 01/2023 - 08/2017
5	Nausea 02/2024 - 01/2010
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2021 - 09/2014
5	Adenocarcinoma 01/2020 - 05/2011
5	Carcinogenesis 01/2019 - 03/2012
4	Melanoma (Melanoma, Malignant) 02/2024 - 01/2022
4	Pneumonia (Pneumonitis) 01/2018 - 12/2016
3	Vomiting 02/2024 - 01/2010
3	Virus Diseases (Viral Diseases) 01/2023 - 01/2017
3	Malignant Mesothelioma 11/2021 - 09/2008
3	Mesothelioma 11/2021 - 09/2008
3	Head and Neck Neoplasms (Head and Neck Cancer) 11/2020 - 06/2007
3	Epilepsy (Aura) 01/2019 - 04/2017
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 03/2014
3	Hypertension (High Blood Pressure) 12/2017 - 08/2010
2	Infections 11/2023 - 11/2023
2	Central Nervous System Diseases (CNS Diseases) 01/2023 - 06/2022
2	Persistent Infection 01/2023 - 01/2018
2	Febrile Neutropenia 01/2023 - 12/2019
2	Exanthema (Rash) 01/2022 - 11/2014
2	Respiratory Insufficiency (Respiratory Failure) 05/2021 - 12/2016
2	Dyspnea (Shortness of Breath) 05/2021 - 09/2008
2	Necrosis 01/2021 - 04/2013

Drug/Important Bio-Agent (IBA)

45	ErbB Receptors (EGF Receptor)IBA 05/2024 - 01/2008
44	osimertinibIBA 03/2024 - 04/2015
27	Tyrosine Kinase InhibitorsIBA 01/2023 - 05/2008
20	Proteins (Proteins, Gene)FDA Link 11/2023 - 03/2010
20	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2012
16	Paclitaxel (Taxol)FDA LinkGeneric 12/2019 - 06/2007
16	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 06/2007
13	B7-H1 AntigenIBA 01/2023 - 01/2018
13	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 09/2008
12	NivolumabIBA 01/2023 - 03/2015
12	PlatinumIBA 01/2023 - 01/2008
11	LigandsIBA 11/2023 - 08/2011
11	Immune Checkpoint InhibitorsIBA 01/2023 - 03/2015
11	Everolimus FDA Link 10/2020 - 08/2010
11	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 12/2008
9	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 12/2012
8	Etoposide (VP 16)FDA LinkGeneric 03/2024 - 01/2014
8	IpilimumabIBA 01/2023 - 05/2018
8	Docetaxel (Taxotere)FDA Link 01/2023 - 11/2008
7	veliparibIBA 11/2021 - 12/2014
7	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2008
7	Monoclonal AntibodiesIBA 01/2019 - 05/2008
7	TOR Serine-Threonine KinasesIBA 01/2019 - 12/2008
7	Anaplastic Lymphoma KinaseIBA 03/2016 - 04/2012
6	Phosphotransferases (Kinase)IBA 12/2022 - 02/2012
6	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2007
5	sotorasibIBA 11/2023 - 01/2020
5	Pemetrexed (MTA)FDA Link 11/2021 - 09/2008
5	MTOR InhibitorsIBA 02/2021 - 12/2008
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020 - 03/2010
5	Sirolimus (Rapamycin)FDA Link 01/2019 - 12/2008
5	Cetuximab (Erbitux)FDA Link 07/2015 - 11/2008
5	Vorinostat FDA Link 10/2010 - 06/2007
4	durvalumabIBA 12/2023 - 01/2021
4	Circulating Tumor DNAIBA 11/2023 - 01/2020
4	AntigensIBA 11/2023 - 06/2012
4	AntibodiesIBA 11/2023 - 01/2016
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2019
4	pembrolizumabIBA 01/2022 - 02/2018
4	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2013
3	binimetinibIBA 02/2024 - 03/2022
3	encorafenibIBA 02/2024 - 03/2022
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 12/2008
3	mobocertinibIBA 01/2023 - 12/2021
3	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2022 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 04/2017
3	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2015
3	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020 - 01/2015
3	Cytotoxins (Cytolysins)IBA 12/2019 - 01/2013
3	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 11/2008
3	human ERBB2 proteinIBA 11/2017 - 03/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 03/2009
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2015 - 03/2011
3	Histone Deacetylases (Histone Deacetylase)IBA 03/2014 - 09/2008
3	Eukaryotic Initiation Factor-4EIBA 03/2013 - 08/2009
2	EnzymesIBA 11/2023 - 08/2010
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2021 - 01/2020
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2021 - 08/2011
2	NVP-BKM120IBA 01/2020 - 12/2012

Therapy/Procedure

93	Therapeutics 01/2024 - 01/2008
43	Drug Therapy (Chemotherapy) 01/2024 - 01/2008
29	Immunotherapy 01/2024 - 01/2015
12	Radiotherapy 11/2019 - 03/2011
4	Precision Medicine 01/2022 - 03/2014
3	Adjuvant Chemotherapy 01/2022 - 03/2016
2	Chemoprevention 11/2020 - 03/2014